IGF-1/IGFBP3

· Shire

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IGF-1/IGFBP3, covering 2017-06-07 to 2017-06-07. Get the full timeline:

Most recent: Clinical Trial Update: IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity [Phase 2]